Regulation of Adenosine Receptor Subtypes during Cultivation of Human Monocytes: Role of Receptors in Preventing Lipopolysaccharide-Triggered Respiratory Burst
Open Access
- 1 March 2004
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (3) , 1349-1357
- https://doi.org/10.1128/iai.72.3.1349-1357.2004
Abstract
Adenosine is a potent anti-inflammatory agent that modulates the function of cells involved in the inflammatory response. Here we show that it inhibits lipopolysaccharide (LPS)-induced formation of reactive oxygen intermediates (ROI) in both freshly isolated and cultured human monocytes. Blocking of adenosine uptake and inactivation of the adenosine-degrading enzyme adenosine deaminase enhanced the inhibitory action of adenosine, indicating that both pathways regulate the extracellular adenosine concentration. Adenosine-mediated inhibition could be reversed by XAC (xanthine amine congener), an antagonist of the adenosine receptor A2A, and MRS 1220 {N-9-chloro-2-(2-furanyl)[1, 2, 4]-triazolo[1,5-c]quinazolin-5-benzeneacetamide}, an A3 receptor antagonist, in both cell populations, while DPCPX (1,3-dipropyl-8-cyclopentylxanthine), an A1 receptor antagonist, had no effect. Similar to what was seen with adenosine, CGS 21680, an A2A and A3 receptor agonist, and IB-MECA, a nonselective A1 and A3 receptor agonist, dose dependently prevented ROI formation, indicating the involvement of A3 and probably also A2A in the suppressive effect of adenosine. Pretreatment of monocytes with adenosine did not lead to changes in the LPS-induced increase in intracellular calcium levels ([Ca2+]i). Thus, participation of [Ca2+]i in the action of adenosine seems unlikely. The adenosine-mediated suppression of ROI production was found to be more pronounced when monocytes were cultured for 18 h, a time point at which changes in the mRNA expression of adenosine receptors were observed. Most prominent was the increase in the A2A receptor mRNA. These data demonstrate that cultivation of monocytes is accompanied by changes in the inhibitory action of adenosine mediated by A3 and probably also the A2A receptor and that regulation of adenosine receptors is an integral part of the monocyte differentiation program.Keywords
This publication has 50 references indexed in Scilit:
- Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slicesBritish Journal of Pharmacology, 1999
- Adenosine A2 Receptor Occupancy Regulates Stimulated Neutrophil Function via Activation of a Serine/Threonine Protein PhosphataseJournal of Biological Chemistry, 1996
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Inhibition of LPS-induced TNFα production in human monocytes by adenosine (A2) receptor selective agonistsInternational Journal of Immunopharmacology, 1995
- Phenotypical and functional characterization of Fey receptor I (CD64)‐negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activityEuropean Journal of Immunology, 1993
- The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Journal of Clinical Investigation, 1993
- Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy.Journal of Histochemistry & Cytochemistry, 1991
- Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.Journal of Clinical Investigation, 1981
- ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLSJournal of Neurochemistry, 1979
- A role for adenosine deaminase in human monocyte maturation.Journal of Clinical Investigation, 1976